Concepedia

Linnéa Bergenholm

LB

6

Publications

251

Citations

6

H-Index

2013

Active since

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Netherlands)

AstraZeneca (Finland)

University of Warwick

Linnéa Bergenholm is an author at AstraZeneca (Sweden) specializing in clinical trials, immunology, and molecular diagnostics.

ORCID

Top concepts

Publications per year

2013–2025

6

Publications

6

Insulin Signaling in Type 2 Diabetes

Cecilia Brännmark, Elin Nyman, Siri Fagerholm et al. · Journal of Biological Chemistry · 2013 · 128 citations · Full text

Parameter Identifiability of Fundamental Pharmacodynamic Models

David Janzén, Linnéa Bergenholm, Mats Jirstrand et al. · Frontiers in Physiology · 2016 · 47 citations · Full text

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials

Javier Armisen, Mitra Rauschecker, Janeli Sarv et al. · Journal of Hepatology · 2025 · 32 citations

, , +8

Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans

Elke Ericson, Linnéa Bergenholm, Anne‐Christine Andréasson et al. · Hepatology Communications · 2022 · 21 citations · Full text

Predicting QRS and PR interval prolongations in humans using nonclinical data

Linnéa Bergenholm, Joanna Parkinson, Jerome T. Mettetal et al. · British Journal of Pharmacology · 2017 · 13 citations · Full text

Rows per page

1–5 of 6